Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Cavo

Showing results (71-80 of 142) with videos related to

Pageof 15
Sort By:
Leukemia & Lymphoma|October 1, 1994
Prognostic factors in autologous stem cell transplantation for multiple myeloma: an EBMT Registry Study. European Group for Bone Marrow TransplantationB Björkstrand, A H Goldstone, P Ljungman, et al.
Haematologica|November 1, 1988
Phase II study with a new alkylating agent (PTT-119) in lymphoid malignanciesS Tura, P Mazza, F Gherlinzoni, et al.
Bone Marrow Transplantation|January 1, 1991
Autologous bone marrow transplantation with immunotoxin purged marrow for multiple myeloma. Long term results in 14 patients with advanced diseaseM Gobbi, P L Tazzari, M Cavo, et al.
European Journal of Haematology|August 1, 1993
Fludarabine in patients with advanced and/or resistant B-chronic lymphocytic leukemiaP L Zinzani, F Lauria, D Rondelli, et al.
Computational and Structural Biotechnology Journal|July 27, 2022
<b></b> : A copy number clustering tool designed to refit and recalibrate the baseline region of tumors' profilesG Mazzocchetti, A Poletti, V Solli, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Phase II study of a new alkylating agent (PTT-119) in resistant-relapsed non-Hodgkin's lymphomasS Tura, P Mazza, F Gherlinzoni, et al.
Haematologica|October 1, 1989
[Allogeneic bone marrow transplantation in multiple myeloma]G Bandini, G Rosti, M Cavo, et al.
Bone Marrow Transplantation|January 1, 1991
Allogenic BMT for multiple myeloma (MM). The Italian experienceM Cavo, S Tura, G Rosti, et al.
Bone Marrow Transplantation|January 11, 2012
Long-term follow-up after autologous stem cell transplantation for light- and heavy-chain deposition diseaseA Brioli, E Zamagni, S Pasquali, et al.
Blood|July 13, 2000
Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myelomaM Cavo, C Terragna, G Martinelli, et al.
Pageof 15

Showing results (71-80 of 142) with videos related to

Sort By:
Pageof 15
Leukemia & Lymphoma|October 1, 1994
Prognostic factors in autologous stem cell transplantation for multiple myeloma: an EBMT Registry Study. European Group for Bone Marrow TransplantationB Björkstrand, A H Goldstone, P Ljungman, et al.
Haematologica|November 1, 1988
Phase II study with a new alkylating agent (PTT-119) in lymphoid malignanciesS Tura, P Mazza, F Gherlinzoni, et al.
Bone Marrow Transplantation|January 1, 1991
Autologous bone marrow transplantation with immunotoxin purged marrow for multiple myeloma. Long term results in 14 patients with advanced diseaseM Gobbi, P L Tazzari, M Cavo, et al.
European Journal of Haematology|August 1, 1993
Fludarabine in patients with advanced and/or resistant B-chronic lymphocytic leukemiaP L Zinzani, F Lauria, D Rondelli, et al.
Computational and Structural Biotechnology Journal|July 27, 2022
<b></b> : A copy number clustering tool designed to refit and recalibrate the baseline region of tumors' profilesG Mazzocchetti, A Poletti, V Solli, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
Phase II study of a new alkylating agent (PTT-119) in resistant-relapsed non-Hodgkin's lymphomasS Tura, P Mazza, F Gherlinzoni, et al.
Haematologica|October 1, 1989
[Allogeneic bone marrow transplantation in multiple myeloma]G Bandini, G Rosti, M Cavo, et al.
Bone Marrow Transplantation|January 1, 1991
Allogenic BMT for multiple myeloma (MM). The Italian experienceM Cavo, S Tura, G Rosti, et al.
Bone Marrow Transplantation|January 11, 2012
Long-term follow-up after autologous stem cell transplantation for light- and heavy-chain deposition diseaseA Brioli, E Zamagni, S Pasquali, et al.
Blood|July 13, 2000
Molecular monitoring of minimal residual disease in patients in long-term complete remission after allogeneic stem cell transplantation for multiple myelomaM Cavo, C Terragna, G Martinelli, et al.
Pageof 15